Perspective Therapeutics
$0.3
10
-$0-0.37% Today
Statistics
Day High
0.31
Day Low
0.29
52W High
0.73
52W Low
0.19
Volume
282,223
Avg. Volume
2,566,459
Mkt Cap
83.44M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
26SepExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.03
-0.02
-0.01
0
Expected EPS
-0.01
Actual EPS
0
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CATX. It's not an investment recommendation.
Analyst Ratings
1.2$Average Price Target
The highest estimate is $1.2.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%
About
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
Show more...
CEO
Lori Woods
Employees
61
Country
US
ISIN
US46489V1044
WKN
000A0MQNM